Ceftobiprole for Staphylococcus aureus Bacteremia. Reply.
Publication
, Journal Article
Holland, TL; Engelhardt, M; Fowler, VG
Published in: N Engl J Med
December 28, 2023
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
December 28, 2023
Volume
389
Issue
26
Start / End Page
2498 / 2499
Location
United States
Related Subject Headings
- Staphylococcus aureus
- Staphylococcal Infections
- Humans
- General & Internal Medicine
- Cephalosporins
- Bacteremia
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holland, T. L., Engelhardt, M., & Fowler, V. G. (2023). Ceftobiprole for Staphylococcus aureus Bacteremia. Reply. N Engl J Med, 389(26), 2498–2499. https://doi.org/10.1056/NEJMc2312883
Holland, Thomas L., Marc Engelhardt, and Vance G. Fowler. “Ceftobiprole for Staphylococcus aureus Bacteremia. Reply.” N Engl J Med 389, no. 26 (December 28, 2023): 2498–99. https://doi.org/10.1056/NEJMc2312883.
Holland TL, Engelhardt M, Fowler VG. Ceftobiprole for Staphylococcus aureus Bacteremia. Reply. N Engl J Med. 2023 Dec 28;389(26):2498–9.
Holland, Thomas L., et al. “Ceftobiprole for Staphylococcus aureus Bacteremia. Reply.” N Engl J Med, vol. 389, no. 26, Dec. 2023, pp. 2498–99. Pubmed, doi:10.1056/NEJMc2312883.
Holland TL, Engelhardt M, Fowler VG. Ceftobiprole for Staphylococcus aureus Bacteremia. Reply. N Engl J Med. 2023 Dec 28;389(26):2498–2499.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
December 28, 2023
Volume
389
Issue
26
Start / End Page
2498 / 2499
Location
United States
Related Subject Headings
- Staphylococcus aureus
- Staphylococcal Infections
- Humans
- General & Internal Medicine
- Cephalosporins
- Bacteremia
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences